Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2023-10-18 | Reverse | 1:10 |
| 1997-04-22 | Forward | 3:1 |
| 1997-01-31 | Forward | 3:1 |
Firefly Neuroscience, Inc. is a Toronto-based AI medical tech company providing Brain Network Analytics to improve diagnosis and treatment of mental and neurological disorders for pharma and clinicians.

The Brain Network Analytics (BNA™) platform is an FDA-cleared AI software that analyzes EEG data to provide objective insights for diagnosing and treating neurological and psychiatric conditions like depression, dementia, and ADHD.
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
ARBE | $0.63 | COMPARE |
NXPL | $9.17 | COMPARE |
MNDO | $1.00 | COMPARE |
CNTM | $5.75 | COMPARE |
SAGT | $0.62 | COMPARE |
ANY | $2.33 | COMPARE |
CXAI | $3.41 | COMPARE |
VEEA | $1.61 | COMPARE |